Oestradiol concentrations in trans women with HIV suppressed on unboosted integrase inhibitor regimens versus trans women without HIV taking oral oestradiol: a pilot study.

Mona LoutfyAshley Lacombe-DuncanAlice TsengYasmeen PersadAngela UnderhillV Logan KennedyIan ArmstrongRaymond FungAmy BournsQuang NguyenSue HranilovicThea WeisdorfL Y L ChanHannah KiaRoberta HalpennyHarshita IyerNirubini JeyarajahGeorge KovchazovJennifer McCullyKimberly K Scarsi

Published in: The Journal of antimicrobial chemotherapy (2023)

Oestradiol concentrations were not statistically different in trans women with HIV compared with those without HIV, suggesting a low probability of clinically relevant drug-drug interactions between FHT and unboosted INSTI-based ART.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
hiv testing
human immunodeficiency virus
hiv aids
hepatitis c virus
men who have sex with men
emergency department
polycystic ovary syndrome
pregnant women
metabolic syndrome
skeletal muscle
insulin resistance